Published in Int J Mol Sci on July 08, 2015
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer (2013) 14.03
Role of platelet-derived growth factors in physiology and medicine. Genes Dev (2008) 8.89
Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev (2004) 5.89
Systematic review of medical treatment in melanoma: current status and future prospects. Oncologist (2011) 2.89
Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Scand (2003) 2.75
Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci U S A (1993) 2.27
L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions. Pigment Cell Melanoma Res (2011) 2.07
Natural products and drug discovery. Can thousands of years of ancient medical knowledge lead us to new and powerful drug combinations in the fight against cancer and dementia? EMBO Rep (2009) 1.97
Melanoma incidence and mortality in Europe: new estimates, persistent disparities. Br J Dermatol (2012) 1.83
Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate. Cancer Res (2004) 1.72
Inhibitors of melanogenesis increase toxicity of cyclophosphamide and lymphocytes against melanoma cells. Int J Cancer (2009) 1.70
Melanoma resistance: a bright future for academicians and a challenge for patient advocates. Mayo Clin Proc (2014) 1.57
Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma. Hum Pathol (2013) 1.50
Skin electroporation for transdermal and topical delivery. Adv Drug Deliv Rev (2004) 1.48
Protection against breast cancer with genistein: a component of soy. Am J Clin Nutr (2000) 1.41
The role of melanogenesis in regulation of melanoma behavior: melanogenesis leads to stimulation of HIF-1α expression and HIF-dependent attendant pathways. Arch Biochem Biophys (2014) 1.36
A new understanding in the epidemiology of melanoma. Expert Rev Anticancer Ther (2010) 1.30
Platelet-derived growth factor receptor (PDGFR): a target for anticancer therapeutics. Drug Resist Updat (2005) 1.20
Soy isoflavone genistein in prevention and treatment of prostate cancer. Prostate Cancer Prostatic Dis (2007) 1.17
Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer. Oncol Rep (2006) 1.14
Genistein inhibits growth of human uveal melanoma cells and affects microRNA-27a and target gene expression. Oncol Rep (2009) 1.08
The role of melanin pigment in melanoma. Exp Dermatol (2015) 1.03
Worldwide increasing incidences of cutaneous malignant melanoma. J Skin Cancer (2011) 0.99
Diagnostic and prognostic biomarkers in melanoma. J Clin Aesthet Dermatol (2014) 0.98
Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems. Int J Pharm (2006) 0.97
Suppression of melanin production by expression of HSP70. J Biol Chem (2010) 0.96
Effect of Genistein on vasculogenic mimicry formation by human uveal melanoma cells. J Exp Clin Cancer Res (2009) 0.95
The distribution of melanin in skin determined in vivo. Br J Dermatol (2007) 0.94
S-100 and NSE as serum markers in melanoma. Acta Oncol (1997) 0.94
Structure and drug release of lamellar liquid crystals containing glycerol. Int J Pharm (2003) 0.93
Platelet-derived growth factors and their receptors in normal and malignant hematopoiesis. Am J Blood Res (2012) 0.92
Electroporation and ultradeformable liposomes; human skin barrier repair by phospholipid. J Control Release (2003) 0.91
Structural characterization and in vivo evaluation of retinyl palmitate in non-ionic lamellar liquid crystalline system. Colloids Surf B Biointerfaces (2011) 0.90
S-100B concentrations predict disease-free survival in stage III melanoma patients. Ann Surg Oncol (2009) 0.90
Lyotropic liquid crystal systems in drug delivery. Drug Discov Today (2010) 0.88
Genistein inhibits growth of B16 melanoma cells in vivo and in vitro and promotes differentiation in vitro. Int J Cancer (1997) 0.88
Non-invasive visualization of melanin and melanocytes by reflectance-mode confocal microscopy. J Invest Dermatol (2005) 0.87
Effect of the isoflavone genistein on tumor size, metastasis potential and melanization in a B16 mouse model of murine melanoma. Nat Prod Commun (2013) 0.86
Epidemiology of melanoma: is it still epidemic? What is the role of the sun, sunbeds, Vit D, betablocks, and others? Dermatol Ther (2012) 0.86
Application of a pigment measuring device--Mexameter--for the differential diagnosis of vitiligo and nevus depigmentosus. Skin Res Technol (2006) 0.85
Topical delivery of active principles: the field of dermatological research. Dermatol Online J (2010) 0.84
Discrimination between cutaneous pigmentation and erythema: comparison of the skin colorimeters Dermacatch and Mexameter. Skin Res Technol (2013) 0.79
Genistein inhibits rat aortic smooth muscle cell proliferation through the induction of p27kip1. J Pharmacol Sci (2008) 0.78
Increasing ceramides sensitizes genistein-induced melanoma cell apoptosis and growth inhibition. Biochem Biophys Res Commun (2012) 0.77
Genistein inhibits PDGF-stimulated proteoglycan synthesis in vascular smooth muscle without blocking PDGFβ receptor phosphorylation. Arch Biochem Biophys (2012) 0.77